Perrigo Company plc filed SEC Form 8-K: Leadership Update
$PRGO
Biotechnology: Pharmaceutical Preparations
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________________________________________
FORM 8-K
______________________________________________
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
+-
Date of Report (Date of earliest event reported):
______________________________________________
(Exact name of registrant as specified in its charter)
_______________________________________________
Commission file number 001-36353
| Not Applicable | ||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
+353 1 7094000
(Address, including zip code, and telephone number, including
area code, of registrant’s principal executive offices)
Not Applicable
(Former name or former address, if changed since last report)
________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
(17 CFR 230.425)
(17 CFR 240.14a-12)
(17 CFR 240.14d-2(b))
(17 CFR 240.13e-4(c))
Securities Registered pursuant to section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
On January 15, 2025, the Board of Directors of Perrigo Company plc (the “Company” or “Perrigo”) appointed Jonas Samuelson to serve as a member of the Company’s board of directors (the “Board”) effective as of January 15, 2025. Mr. Samuelson will also serve on the Audit Committee and the Nominating and Governance Committee of the Board.
Mr. Samuelson brings substantial CEO, CFO and Board experience from both public and private companies. Most recently, he served as President, CEO and board member of AB Electrolux, where he also previously served as CFO for the Electrolux Group. Additionally, Mr. Samuelson served as CFO and Executive Vice President for Munters AB and held leadership roles in commercial finance, treasury and business planning and analysis with General Motors and Saab Automobile AB.
There are no arrangements or understandings between Mr. Samuelson and any other person pursuant to which he was selected as a director of the Company. For his service on the Board, Mr. Samuelson will be entitled to receive compensation provided to non-employee directors as approved by the Board and described in the Company’s proxy statement filed on March 22, 2024.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| (Registrant) | ||||||||||||||
| PERRIGO COMPANY PLC | ||||||||||||||
| By: | /s/ Charles Atkinson | |||||||||||||
| Dated: | January 16, 2025 | Charles Atkinson | ||||||||||||
| General Counsel & Company Secretary | ||||||||||||||